Peter Langmann

720 total citations
37 papers, 555 citations indexed

About

Peter Langmann is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Peter Langmann has authored 37 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 19 papers in Epidemiology and 12 papers in Virology. Recurrent topics in Peter Langmann's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). Peter Langmann is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). Peter Langmann collaborates with scholars based in Germany, Spain and United States. Peter Langmann's co-authors include Hartwig Klinker, Michael Zilly, Benedikt Weißbrich, Ralf Winzer, Erik A. Richter, Steffen Desch, Jörg Schubert, Franz Tollmann, Ernst Richter and Werner Heinz and has published in prestigious journals such as Spine, Antimicrobial Agents and Chemotherapy and Journal of Chromatography B.

In The Last Decade

Peter Langmann

36 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Langmann Germany 15 348 199 151 79 78 37 555
Aurélie Barrail‐Tran France 16 387 1.1× 194 1.0× 112 0.7× 117 1.5× 57 0.7× 35 639
Michael Zilly Germany 12 281 0.8× 169 0.8× 97 0.6× 73 0.9× 55 0.7× 17 376
Gregory E. Chittick United States 15 484 1.4× 287 1.4× 198 1.3× 90 1.1× 127 1.6× 18 798
Rosa Ruiz-Valderas Spain 12 342 1.0× 160 0.8× 189 1.3× 35 0.4× 38 0.5× 26 457
Elizabeth Gould United States 12 540 1.6× 387 1.9× 169 1.1× 57 0.7× 62 0.8× 15 719
Catherine Knupp United States 7 320 0.9× 232 1.2× 170 1.1× 54 0.7× 30 0.4× 9 471
Rosa F. Yeh United States 12 348 1.0× 166 0.8× 135 0.9× 62 0.8× 140 1.8× 25 682
Neil Buss Switzerland 13 375 1.1× 252 1.3× 130 0.9× 71 0.9× 61 0.8× 17 655
Tsunefusa Hayashida Japan 14 423 1.2× 277 1.4× 202 1.3× 57 0.7× 83 1.1× 31 655
R Cvetković New Zealand 6 278 0.8× 85 0.4× 68 0.5× 60 0.8× 49 0.6× 10 543

Countries citing papers authored by Peter Langmann

Since Specialization
Citations

This map shows the geographic impact of Peter Langmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Langmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Langmann more than expected).

Fields of papers citing papers by Peter Langmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Langmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Langmann. The network helps show where Peter Langmann may publish in the future.

Co-authorship network of co-authors of Peter Langmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Langmann. A scholar is included among the top collaborators of Peter Langmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Langmann. Peter Langmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinz, Werner, et al.. (2010). High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid. Cancer Chemotherapy and Pharmacology. 68(1). 239–245. 35 indexed citations
2.
Winzer, Ralf & Peter Langmann. (2009). Tipranavir: A Review of its Use in Therapy of HIV Infection. 1. CMT.S2668–CMT.S2668. 1 indexed citations
3.
Hammerschmidt, Stefan, Hans Wahn, Peter Langmann, & W Scheppach. (2008). Akutes Leberversagen nach Hyperthermiebehandlung. DMW - Deutsche Medizinische Wochenschrift. 124(46). 1379–1382.
4.
Langmann, Peter, et al.. (2008). Safety of long-term lopinavir plasma-levels in patients with liver disease.. PubMed. 13(5). 205–8. 3 indexed citations
5.
6.
Winzer, Ralf, Peter Langmann, Michael Zilly, et al.. (2005). No influence of the P-glycoprotein polymorphisms MDR1 G2677T/A and C3435T on the virological and immunological response in treatment naïve HIV-positive patients. Annals of Clinical Microbiology and Antimicrobials. 4(1). 3–3. 25 indexed citations
7.
Tappe, Dennis, Peter Langmann, Michael Zilly, et al.. (2004). Osteomyelitis and skin ulcers caused by Mycobacterium szulgai in an AIDS patient. Scandinavian Journal of Infectious Diseases. 36(11-12). 883–885. 19 indexed citations
8.
Benesic, Andreas, Michael Zilly, Friedrich Kluge, et al.. (2004). Lipid Lowering Therapy with Fluvastatin and Pravastatin in Patients with HIV Infection and Antiretroviral Therapy: Comparison of Efficacy and Interaction with Indinavir. Infection. 32(4). 229–33. 53 indexed citations
9.
Zilly, Michael, Peter Langmann, Ralf Winzer, et al.. (2004). Liquid chromatographic method for the determination of uridine in human serum. Journal of Chromatography B. 803(2). 345–351. 3 indexed citations
10.
Kurzai, Oliver, W. Hamelmann, Hartwig Klinker, et al.. (2003). Combined surgical and antifungal treatment of a subcutaneous infection due to <emph type="2">Paecilomyces lilacinus</emph>. Medical Mycology. 41(3). 253–258. 9 indexed citations
11.
Zilly, Michael, et al.. (2003). Highly sensitive gas chromatographic determination of ethanol in human urine samples. Journal of Chromatography B. 798(2). 179–186. 11 indexed citations
12.
Langmann, Peter, et al.. (2002). Therapeutic Drug Monitoring of Indinavir in HIV-Infected Patients Undergoing HAART. Infection. 30(1). 13–16. 21 indexed citations
13.
Langmann, Peter, et al.. (2002). Rapid determination of nevirapine in human plasma by gas chromatography. Journal of Chromatography B. 767(1). 69–74. 11 indexed citations
14.
Zhang, Ying, M Huber, Benedikt Weißbrich, et al.. (2001). Characterization of HIV-Specific Proliferative T Cell Responses in HIV-Infected Persons. AIDS Research and Human Retroviruses. 17(7). 623–629. 5 indexed citations
15.
Langmann, Peter, et al.. (2001). High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy. Journal of Chromatography B Biomedical Sciences and Applications. 755(1-2). 151–156. 38 indexed citations
16.
17.
Klinker, Hartwig, Peter Langmann, Michael Zilly, & Ernst Richter. (1998). Drug monitoring during the treatment of AIDS‐associated Pneumocystis carinii pneumonia with trimethoprim‐sulfamethoxazole. Journal of Clinical Pharmacy and Therapeutics. 23(2). 149–154. 19 indexed citations
18.
Klinker, Hartwig, Peter Langmann, & Erik A. Richter. (1996). Pyrimethamine alone as prophylaxis for cerebral toxoplasmosis in patients with advanced HIV infection. Infection. 24(4). 324–327. 8 indexed citations
19.
Klinker, Hartwig, Peter Langmann, & Erik A. Richter. (1996). Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS. Antimicrobial Agents and Chemotherapy. 40(7). 1623–1627. 21 indexed citations
20.
Ernemann, Ulrike, et al.. (1990). Gas chromatographic determination of trimethoprim in plasma during high-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis carinii pneumonia. Journal of Chromatography B Biomedical Sciences and Applications. 528(1). 243–249. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurélie Barrail‐Tran Breakdown of academic impact, for papers by Michael Zilly Breakdown of academic impact, for papers by Gregory E. Chittick Breakdown of academic impact, for papers by Rosa Ruiz-Valderas Breakdown of academic impact, for papers by Elizabeth Gould Breakdown of academic impact, for papers by Catherine Knupp Breakdown of academic impact, for papers by Rosa F. Yeh Breakdown of academic impact, for papers by Neil Buss Breakdown of academic impact, for papers by Tsunefusa Hayashida Breakdown of academic impact, for papers by R Cvetković
Rankless by CCL
2026